If Aetna denies coverage for Ozempic, patients can explore alternatives like other GLP-1s, compounded semaglutide, or non-GLP-1 medications, along with lifestyle and nutrition programs often included in Aetna plans
Raun K, Fels JJ, Rosenquist C, et al
-Safety remained consistent with prior semaglutide studies, but efficacy was not demonstrated
Proper needles help deliver measured water volumes into peptide vials
Skinny labeling, enabled by Section viii of the Hatch-Waxman Act, allows a generic manufacturer to seek approval for a drug for unpatented indications while carving out patented uses from the label
Baum L, Cheung SK, Mok VC, et al